118th Congress · HOUSE BILLBILL

H.R. 1629 — Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023

“To make hemp, cannabidiol derived from hemp, and any other ingredient derived from hemp lawful for use under the Federal Food, Drug, and Cosmetic Act as a dietary ingredient in a dietary supplement, and for other purposes.”

Health

Introduced Mar 17, 2023

Last action Mar 24, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 17, 2023

Step 2

Referred

Mar 24, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill allows the use of hemp, cannabidiol (i.e., CBD) derived from hemp, or any other ingredient derived from hemp in a dietary supplement, provided that the supplement meets other applicable requirements. (Currently, the Food and Drug Administration's position is that CBD products may not be sold as dietary supplements.)

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Mar 24, 2023

Referred to the Subcommittee on Health.

Mar 17, 2023

Introduced in House

Mar 17, 2023

Referred to the House Committee on Energy and Commerce.